...
首页> 外文期刊>Oriental pharmacy and experimental medicine >Renoprotective effects of oryzanol in an animal model of experimentally induced diabetic nephropathy
【24h】

Renoprotective effects of oryzanol in an animal model of experimentally induced diabetic nephropathy

机译:谷维素对实验性糖尿病肾病动物模型的肾脏保护作用

获取原文
获取原文并翻译 | 示例
           

摘要

Hyperglycemia-mediated oxidative stress is an important causal factor for the development and progression of diabetic nephropathy. Hence, the present study was hypothesized to explore the renoprotective potential of oryzanol, a commercially-important antioxidant component isolated from crude rice bran oil, in diabetes-induced experimental nephropathy. Wistar rats were administered streptozotocin (45 mg/kg i.v., once) to induce experimental diabetes mellitus. Animals were then divided into the following groups; normal control rats, diabetic rats, diabetic rats administered with oryzanol (50 and 100 mg/kg) and diabetic rats administered with standard glibenclamide (10 mg/kg) orally. Following 8 weeks of streptozotocin injection and respective treatments, fasting blood glucose, biochemical markers of renal function and renal oxidative stress were evaluated in serum, urine and kidney tissue, together with histopathological assessment. The results revealed that treatment with oryzanol significantly improved the glycemic status and renal function in diabetic rats with respect to marked normalization on the levels of creatinine, uric acid, blood urea nitrogen, albumin, urinary albumin:creatinine ratio, kidney tissue enzyme, total protein, serum lipid profile and electrolyte concentrations in a dose-dependent manner. Further, oryzanol supplementation revealed a considerable dose-dependent improvement in superoxide dismutase and catalase activities and reduced glutathione levels, with a significant decline in the extent of lipid peroxidation in diabetic kidneys. Histopathological observations also evidenced regression in renal pathological alterations with oryzanol. Therefore, oryzanol confers marked protection against functional and morphologic injuries in the kidneys of diabetic rats by modulating renal alterations, improving serum lipid profile and attenuating the markers of oxidative and/or nitrosative stress in renal tissues.
机译:高血糖介导的氧化应激是糖尿病肾病发生和发展的重要原因。因此,假设本研究旨在探索谷维素(一种从米糠油中分离出的商业上重要的抗氧化剂成分)在糖尿病引起的实验性肾病中的肾脏保护潜力。向Wistar大鼠施用链脲佐菌素(45mg / kg,静脉内一次)以诱导实验性糖尿病。然后将动物分为以下几组:正常对照组大鼠,糖尿病大鼠,口服谷维素(50和100 mg / kg)的糖尿病大鼠和口服标准格列本脲(10 mg / kg)的糖尿病大鼠。注射链脲佐菌素8周并进行相应的治疗后,对血清,尿液和肾脏组织中的空腹血糖,肾功能和肾氧化应激的生化指标进行了评估,并进行了组织病理学评估。结果表明,相对于肌酐,尿酸,血尿素氮,白蛋白,尿白蛋白:肌酐比例,肾脏组织酶,总蛋白水平的显着正常化,谷维素处理可显着改善糖尿病大鼠的血糖状况和肾功能。 ,血脂水平和电解质浓度呈剂量依赖性。此外,谷维素的补充显示了超氧化物歧化酶和过氧化氢酶活性的显着剂量依赖性改善和谷胱甘肽水平降低,糖尿病肾脏中脂质过氧化程度显着下降。组织病理学观察还证实了谷维素对肾病理改变的消退。因此,谷维素可通过调节肾脏改变,改善血脂水平和减弱肾脏组织中氧化和/或亚硝化应激的标志物,对糖尿病大鼠肾脏的功能和形态损伤提供明显的保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号